Screener
Collegium Pharmaceutical, Inc. COLL Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
FAQ
- What is Collegium Pharmaceutical, Inc.'s total liabilities?
- Collegium Pharmaceutical, Inc. (COLL) reported total liabilities of $38.53M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s total liabilities changed year-over-year?
- Collegium Pharmaceutical, Inc.'s total liabilities decreased by 97.2% year-over-year, from $1.36B to $38.53M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s total liabilities has grown at a 24.2% compound annual growth rate (CAGR), from $457.81M to $1.36B.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Collegium Pharmaceutical, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude